Moelis & Company operates as an investment banking advisory firm in the United States, Europe, and internationally. It offers advisory services in the areas of mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters. The company offers its services to public multinational corporations, middle market private companies, financial sponsors, entrepreneurs, and governments. It has strategic alliances with Sumitomo Mitsui Banking Corporation and SMBC Nikko Securities Inc.; and Alfaro, Dávila y Scherer, S.C. The company was founded in 2007 and is headquartered in New York, New York.
IPO Year: 2014
Exchange: NYSE
Website: moelis.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/13/2025 | $100.00 → $70.00 | Overweight → Underweight | Morgan Stanley |
| 12/20/2024 | $71.00 → $86.00 | Mkt Perform → Outperform | Keefe Bruyette |
| 12/9/2024 | $66.00 → $92.00 | Underweight → Overweight | Morgan Stanley |
| 9/12/2024 | $70.00 | Equal Weight | Wells Fargo |
| 3/13/2024 | $53.00 → $58.00 | Sell → Neutral | Goldman |
| 1/29/2024 | $56.00 | Mkt Perform | Keefe Bruyette |
| 1/11/2023 | $40.00 → $37.00 | Neutral → Sell | Goldman |
| 11/3/2022 | $40.00 → $37.00 | Mkt Perform → Underperform | Keefe Bruyette |
| 9/23/2022 | $43.00 → $35.00 | Neutral → Sell | UBS |
| 7/18/2022 | $53.00 → $36.00 | Equal-Weight → Underweight | Morgan Stanley |
Morgan Stanley downgraded Moelis from Overweight to Underweight and set a new price target of $70.00 from $100.00 previously
Keefe Bruyette upgraded Moelis from Mkt Perform to Outperform and set a new price target of $86.00 from $71.00 previously
Morgan Stanley upgraded Moelis from Underweight to Overweight and set a new price target of $92.00 from $66.00 previously
Wells Fargo initiated coverage of Moelis with a rating of Equal Weight and set a new price target of $70.00
Goldman upgraded Moelis from Sell to Neutral and set a new price target of $58.00 from $53.00 previously
Keefe Bruyette resumed coverage of Moelis with a rating of Mkt Perform and set a new price target of $56.00
Goldman downgraded Moelis from Neutral to Sell and set a new price target of $37.00 from $40.00 previously
Keefe Bruyette downgraded Moelis from Mkt Perform to Underperform and set a new price target of $37.00 from $40.00 previously
UBS downgraded Moelis from Neutral to Sell and set a new price target of $35.00 from $43.00 previously
Morgan Stanley downgraded Moelis from Equal-Weight to Underweight and set a new price target of $36.00 from $53.00 previously
4 - Moelis & Co (0001596967) (Issuer)
4 - Moelis & Co (0001596967) (Issuer)
4 - Moelis & Co (0001596967) (Issuer)
4 - Moelis & Co (0001596967) (Issuer)
4 - Moelis & Co (0001596967) (Issuer)
4 - Moelis & Co (0001596967) (Issuer)
4 - Moelis & Co (0001596967) (Issuer)
4 - Moelis & Co (0001596967) (Issuer)
4 - Moelis & Co (0001596967) (Issuer)
3 - Moelis & Co (0001596967) (Issuer)
8-K - Moelis & Co (0001596967) (Filer)
8-K - Moelis & Co (0001596967) (Filer)
8-K - Moelis & Co (0001596967) (Filer)
S-8 - Moelis & Co (0001596967) (Filer)
10-K - Moelis & Co (0001596967) (Filer)
8-K - Moelis & Co (0001596967) (Filer)
144 - Moelis & Co (0001596967) (Subject)
144 - Moelis & Co (0001596967) (Subject)
144 - Moelis & Co (0001596967) (Subject)
8-K - Moelis & Co (0001596967) (Filer)